Perioperative Chemo/Immunotherapies in Lung Cancer: A Critical Review on the Value of Perioperative Sequences

Resectable non-small cell lung cancer (NSCLC) continues to pose significant challenges with high recurrence and mortality rates, despite traditional platinum-based chemotherapy yielding only an approximate 5% improvement in 5-year overall survival when administered preoperatively or postoperatively....

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Thoma’ Dario Clementi, Francesca Colonese, Stefania Canova, Maria Ida Abbate, Luca Sala, Francesco Petrella, Gabriele Giuseppe Pagliari, Diego Luigi Cortinovis
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Subjects:	perioperative in lung cancer resectable/early-stage NSCLC chemo-immunotherapies for NSCLC neoadjuvant ICIs
Online Access:	https://www.mdpi.com/1718-7729/32/7/397